PHMMF Stock: Pharma Mar, S.A. Stock Price, Analysis & Insights
Get live PHMMF stock price $106.48, comprehensive Pharma Mar, S.A. stock analysis, charts, news, and expert forecast. Real-time PHMMF stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Pharma Mar, S.A. is a biopharmaceutical firm dedicated to the discovery, development, manufacturing, and commercialization of bioactive compounds derived from marine organisms, primarily targeting oncology applications. Its products and research init...
Company Information
- CEO
- Jose Maria Fernandez Sousa-Faro
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 500
Contact Information
- Website
- https://www.pharmamar.com
- Address
- Avenida de los Reyes, 1
- Country
- ES
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 46.3)
✓ Lower volatility stock (Beta: 0.41) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Pharma Mar, S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Pharma Mar, S.A.
- ⚠Investors should consider how Pharma Mar, S.A. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 46.3) requires strong growth to justify
Market Cap
1.84B
P/E Ratio (TTM)
46.29
Beta
0.41
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PHMMF with peer companies:
- Price
- $26.00
- Market cap
- 1.02B
- Price
- $0.70
- Market cap
- 1.11B
- Price
- $31.07
- Market cap
- 2.06B
- Price
- $8.67
- Market cap
- 2.02B
- Price
- $14.00
- Market cap
- 997.75M
- Price
- $83.91
- Market cap
- 1.67B
- Price
- $1.55
- Market cap
- 2.00B
- Price
- $8.88
- Market cap
- 1.12B
- Price
- $1.70
- Market cap
- 1.65B
- Price
- $5.98
- Market cap
- 768.38M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.